Genetic testing for hereditary prostate cancer

Nearly 1 in 6 prostate cancer patients has a germline disease-causing genetic variant. A recent study in JAMA Oncology examining 3607 men with a personal history of prostate cancer has found that 17% had a germline disease-causing genetic variant.  This study has...

Solid Tumours (Oncomine Focus)

We are pleased to announce the launch our Next Generation Sequencing panel for Solid tumours (Oncomine Focus assay). This has been done in an attempt to improve and streamline our molecular pathology testing offering.  As opposed to testing for single gene anomalies...

Pin It on Pinterest